REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 115 filers reported holding REVANCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,185,429 | +257.2% | 713,638 | +688.3% | 0.02% | +325.0% |
| Q2 2023 | $2,291,264 | +105.5% | 90,528 | +119.4% | 0.00% | +100.0% |
| Q3 2022 | $1,115,000 | +378.5% | 41,253 | +144.7% | 0.00% | – |
| Q2 2022 | $233,000 | -90.3% | 16,858 | -86.2% | 0.00% | -100.0% |
| Q1 2022 | $2,391,000 | +147.5% | 122,598 | +99.8% | 0.01% | 0.0% |
| Q1 2019 | $966,000 | – | 61,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |